CSL222 (etranacogene dezaparvovec)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CSL222 (etranacogene dezaparvovec), covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs) [Phase 3]